A Study Evaluating the Efficacy and Safety of ST-0529 in Subjects With Moderately to Severely Active Ulcerative Colitis
Status:
Terminated
Trial end date:
2021-04-14
Target enrollment:
Participant gender:
Summary
Study CYC-202 is a multicenter, randomized, double-blind, placebo-controlled, parallel-group
study to evaluate the efficacy and safety of ST-0529 in subjects with moderately to severely
active UC, defined as a score of 5 to 9 on the 3-Component Adapted Mayo Score (comprised of
rectal bleeding, stool frequency and endoscopy sub-scores; score range 0-9).